Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Cash from Financing Activities (2016 - 2026)

Dexcom has reported Cash from Financing Activities over the past 17 years, most recently at -$25.0 million for Q1 2026.

  • Quarterly Cash from Financing Activities fell 300.0% to -$25.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.7 billion through Mar 2026, down 137.13% year-over-year, with the annual reading at -$1.7 billion for FY2025, 129.5% down from the prior year.
  • Cash from Financing Activities was -$25.0 million for Q1 2026 at Dexcom, up from -$1.5 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $939.5 million in Q2 2023 and troughed at -$1.5 billion in Q4 2025.
  • The 5-year median for Cash from Financing Activities is -$1.7 million (2025), against an average of -$195.1 million.
  • Year-over-year, Cash from Financing Activities soared 21948.84% in 2023 and then tumbled 95037.5% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.0 million in 2022, then tumbled by 63090.0% to -$631.9 million in 2023, then soared by 99.75% to -$1.6 million in 2024, then tumbled by 95037.5% to -$1.5 billion in 2025, then surged by 98.36% to -$25.0 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Cash from Financing Activities are -$25.0 million (Q1 2026), -$1.5 billion (Q4 2025), and -$175.0 million (Q3 2025).